C

Cutia Therapeutics
HKEX:2487

Watchlist Manager
Cutia Therapeutics
HKEX:2487
Watchlist
Price: 6.83 HKD -2.01% Market Closed
Market Cap: 2.2B HKD
Have any thoughts about
Cutia Therapeutics?
Write Note
Financials Section:
Income Statement Balance Sheet Cash Flow Statement

Balance Sheet

1.5B
-12%
Assets
Jun 30, 2024 1.5B
Dec 31, 2023 1.7B
Jun 30, 2023 1.8B
319.4m
-11%
Liabilities
Jun 30, 2024 319.4m
Dec 31, 2023 357.8m
Jun 30, 2023 172.4m
1.2B
-12%
Equity
Jun 30, 2024 1.2B
Dec 31, 2023 1.3B
Jun 30, 2023 1.6B

Balance Sheet Decomposition
Cutia Therapeutics

1.5B
Assets
319.4m
Liabilities
1.5B
Assets
319.4m
Liabilities
Current Assets 1.2B
Cash & Short-Term Investments 1B
Receivables 63.3m
Other Current Assets 107.7m
Non-Current Assets 297.7m
PP&E 227.6m
Intangibles 8.2m
Other Non-Current Assets 61.8m
Current Liabilities 237.8m
Accounts Payable 60m
Accrued Liabilities 28.6m
Short-Term Debt 130.3m
Other Current Liabilities 18.8m
Non-Current Liabilities 81.7m
Long-Term Debt 81.7m

Balance Sheet
Cutia Therapeutics

Rotate your device to view
Balance Sheet
Currency: CNY
Dec-2021 Dec-2022 Dec-2023
Assets
Cash & Cash Equivalents
203
466
473
Cash Equivalents
203
466
473
Short-Term Investments
1 175
611
800
Total Receivables
1
4
77
Accounts Receivables
0
0
62
Other Receivables
1
4
15
Inventory
2
20
45
Other Current Assets
21
45
21
Total Current Assets
1 402
1 145
1 416
PP&E Net
51
229
231
PP&E Gross
51
229
231
Accumulated Depreciation
6
17
48
Intangible Assets
0
1
8
Note Receivable
14
37
42
Other Long-Term Assets
28
35
10
Total Assets
1 495
N/A
1 447
-3%
1 707
+18%
Liabilities
Accounts Payable
0
0
134
Accrued Liabilities
13
38
49
Short-Term Debt
0
0
89
Current Portion of Long-Term Debt
4
9
51
Other Current Liabilities
2
31
45
Total Current Liabilities
19
77
255
Long-Term Debt
2 266
2 615
103
Other Liabilities
0
0
0
Total Liabilities
2 285
N/A
2 693
+18%
358
-87%
Equity
Common Stock
0
0
0
Retained Earnings
1 050
1 506
3 337
Additional Paid In Capital
259
259
4 686
Total Equity
791
N/A
1 246
-58%
1 349
N/A
Total Liabilities & Equity
1 495
N/A
1 447
-3%
1 707
+18%
Shares Outstanding
Common Shares Outstanding
304
304
304

See Also

Summary
Intrinsic value, competitors valuation, and company profile.
DCF Valuation
Stock valuation using Discount Cash Flow valuation method.
Relative Valuation
Stock valuation using valuation multiples.
Wall Street Estimates
Price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
Stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
ALPHA SPREAD
Follow us
Join more than 210,200+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.